On Friday, the Food and Drug Administration (FDA) will vote on whether to approve the use of fetal growth medication (FGM) for a condition in which girls and women have been given the procedure in the past.
In addition to fetal growth therapy, which is currently approved in Europe, the drug will also be approved in the United States.
The FDA’s decision could come as soon as next week, although it’s possible it could be delayed.
What does the FDA’s vote mean?
The FDA voted last year to approve FGM in the U.S. for a variety of reasons.
The decision means that women in the country can now receive a treatment for the condition known as fibrocystic ovary syndrome (FCOS), which affects up to 3.5 percent of the U